Johnson & Johnson Expects 2023 Adjusted EPS Of $10.00-$10.10 (Vs. Previous Guidance Of $10.70–$10.80 And Consensus Of $10.65.) And Adjusted Operational EPS Of $9.90 - $10.00 (Vs. Prior Guidance Of $10.60–$10.70)
Portfolio Pulse from Benzinga Newsdesk
Johnson & Johnson has revised its 2023 adjusted EPS guidance to $10.00-$10.10, down from the previous guidance of $10.70-$10.80. The consensus was $10.65. The company also adjusted its operational EPS to $9.90 - $10.00, down from the prior guidance of $10.60-$10.70.
August 30, 2023 | 10:40 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Johnson & Johnson has lowered its 2023 adjusted EPS guidance, which could negatively impact investor sentiment and potentially the stock price in the short term.
Johnson & Johnson has lowered its 2023 adjusted EPS guidance, which is a key metric for investors. This downward revision could negatively impact investor sentiment and potentially lead to a decrease in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100